Lumretuzumab

Lumretuzumab (RG7116) (INN) is a humanized monoclonal antibody designed for the treatment of cancer.'-mexi-' (melanoma): Ecromeximab§ Lumretuzumab (RG7116) (INN) is a humanized monoclonal antibody designed for the treatment of cancer. This drug was developed by Genentech/Roche.